Arrangement - Side 3

Det dukker ofte opp en lege i Ibsens verker. Ibsens leger har ofte høy status og skaper spenning i handlingen. Legen kan være en kjær og tillitsvekkende venn og en som fortrolig lytter til familiens mange hemmeligheter – eller den som kommer med en brannfakkel og skaper røre.

SPARK Norway Educational Forum are monthly open meetings organized by UiO:Life Science and SPARK Norway partners.

Dr. Ville Mustonen, Professor at the Department of Computer Science and Institute of Biotechnology, University of Helsinki and the Helsinki Institute for Information Technology, Finland, will present the lecture "Using computational methods and evolutionary theory to combat drug resistance."

Dr. Evangelia Petsalaki, Group Leader at EMBL-EBI, will present the lecture entitled "Integrative studies of context-specific signalling."

SPARK Norway Educational Forum are monthly open meetings organized by UiO:Life Science and SPARK Norway partners.

Dr. Florian Markowetz, Group Leader of the Integrative Cancer Biology team at the Cancer Research UK Cambridge Institute, Cambridge, UK, will present his current research.

SPARK Norway Educational Forum are monthly open meetings organized by UiO:Life Science and SPARK Norway partners.

Having a new idea is not enough to create a new innovation. The hardest part is to build a successful business around it – this is the entrepreneurial challenge. One of the key elements that needs to be worked out is the right Go-To-Market strategy.

Dr. Matti Nykter, Professor at the Tampere University, Finland, will present the lecture "Computational analysis to understand aberrant gene expression and treatment induced responses in prostate cancer."

To develop your idea into a growing business you need an excellent and well-functioning team. Learn more about what it takes to build a team and establish and grow a successful business and use the opportunity to discuss with an experienced industry expert during this interactive seminar.

Dr. Colm Ryan, Assistant Professor at the University College Dublin, will present the lecture "Identifying robust genetic interactions in cancer."

Forming a business partnership can be beneficial or even vital to obtain success, but it has to be done correctly. If not, it can be catastrophic. Learn more about what it takes to secure a successful partnering and finance setup. What are the pitfalls? What is critical? What are the dos and don'ts?

Procedures that work in the lab don’t always scale-up seamlessly into production in the life science industry. Process development while staying compliant will be required. What should be considered when you work in lab-scale to make the transition to production smoother? What are the common pitfalls, and what are the dos and don’ts?

Dr. Tero Aittokallio, Professor at the Oslo Centre for Biostatistics and Epidemiology and Group Leader at the Institute for Cancer Research, Oslo, Norway, will present his lecture "Predictive modelling of drug combination effects for precision medicine."

Vi feirer 50-årsdagen for Odd Hassels Nobelpris i kjemi: Program og påmelding til Hassel-seminaret 31. oktober til og med 1. november. 

This symposium brings together world leaders in the ER proteostasis field in Oslo to showcase new research in this burgeoning field and its links to different aspects of normal cellular function as well as disease states, and aims stimulate new collaborative research.

Repurposing of drugs can potentially bring medications with known safety profiles to new patient groups. What is the industry looking for when they consider to invest in a repurposing project? What is the regulatory framework in this area? How is IP handled?

We are pleased to announce that Dr. Adam Novak will be the guest speaker of our upcoming Sven Furberg Seminar in Bioinformatics and Statistical Genomics on the coming Friday, Sep 27, at 14:30 in Lille auditorium, Kristen Nygaards hus.

Dr. Adam Novak, senior software engineer in the UCSC Genomics Institute, will present his lecture "Graph-based genome representations".

Abstract:

Graph-based approaches to genomics problems can beat out traditional linear-reference-based tools, reducing reference allele bias and improving structural variant calling. For these reasons and others, graph genomics techniques are becoming more popular, and more graph-based tools are being developed. Here I present lessons on genome graph API design learned during the development of the vg variation graph toolkit. I show how techniques and libraries extracted from vg can be used to help developers quickly bootstrap new graph-based projects, forming an ecosystem of interoperable graph genomics tools.

UiO satser stort på livsvitenskap og ønsker å bidra til ny helsenæring. Thermo Fisher Scientific er ett av firmaene som har lykkes med å ta norske forskningsresultater videre til anvendelse over hele verden, samtidig som de har bevart aktivitet i Norge. Hva ser de etter hos studenter fra UiO, og hva kan de tilby? Møt også en ung forsker fra UiO:Livsvitenskaps innovasjonsprogram SPARK Norway.

Skal universitetet spille en rolle i å løse klimakrisen? Hvilken effekt har skolestreikene? Må professorer fly, og hvordan skal vi utdanne fremtidige studenter til et bærekraftig arbeidsliv? Vi tar debattene på Kulturhuset.

Hvorfor er medisinske forskere opptatt av torsken? Har du hørt lyden av torsk? Test dine kunnskaper i den store torskequizen og vinn fine premier.

Hva skulle vi gjort uten havet? Bli med på en bevisstgjørende frokost med forskere fra UiO og kunstnere. Vi dypdykker ned i det mørke, store blå og får myter knust og fakta formidlet.

A part of Nordic Life Science Awards that features exciting academic projects from five Nordic countries illustrating the rich and broad research milieus and their motivation to advance their ideas into innovations for patients.

Clinical trials are essential to develop new treatments. What are the fundamental issues that must be considered when designing clinical trials? What are the pitfalls? What are the dos and don’ts?

The UiO:Life Science ImmunoLingo Convergence Environment Symposium.

The scope of the workshop: This international workshop brings together scientist from a wide range of fields with a special interest in bio-mechanics phenomena from cellular scale to the size of organs. Through a series of short talks the participants will present their work, where the workshop strives to stimulate scientific exchange and to initiate new collaborations.

På tide med ny mobil, eller kan du bruke den gamle litt lenger? Norge ligger på verdenstoppen i produksjon av elektronisk avfall. Miljøgiftene fra avfallet fordeler seg i miljøet og tas opp i planter og dyr. Hvordan må vi jobbe lokalt, nasjonalt og internasjonalt for å få bukt med problemet? Hvordan kan politikere og forbrukere bidra til gode løsninger?

Patent strategy is an important part of the innovation process. On this seminar you will hear from experts from Inven2 and learn how you can build a solid patent strategy.

Dr. Mark Robinson, Associate Professor of Statistical Genomics, Institute of Molecular Life Sciences, University of Zurich, Switzerland, will present his lecture "Statistical methods for flexible differential analysis of multi-sample multi-condition single-cell RNA-seq datasets."

Bli kjent med det nye digitale læringsuniverset i bioteknologi og livsvitenskap. Temaene er knyttet opp mot sentrale kompetansemål i naturfag, samfunnsfag og KRLE, og egner seg godt for tverrfaglig arbeid.

Solid research is the basis for all new innovations. However, too often data generated in academia turns out to be irreproducible by others and therefor fail in translation to new products and treatments. What does it take to achieve reproducible high quality data?

Dr. Günter Klambauer, Institute for Bioinformatics, Johannes Kepler University Linz, Austria, will present the lecture "Deep Learning methods in early-stage drug discovery."

Dr. Pekka Marttinen, Assistant Professor, Helsinki Institute for Information Technology HIIT, Aalto University, Finland, will present the lecture "A Bayesian model of acquisition and clearance of bacterial colonization incorporating within-host variation."

Time and again, a product is being developed, approved, and launched, only to flop in the marketplace. So how can you get your ducks in a row to prepare for a successful product, and how early should you start this process? The answer: begin with the end in mind by creating and using a Target Product Profile (TPP).

Dr. Anne-Laure Boulesteix, associate professor at the Department of Medical Informatics, Biometry and Epidemiology of the Faculty of Medicine, Ludwig Maximilian University of Munich, Germany, will present her lecture "A plea for benchmarking and against fishing expeditions with focus on the statistical analysis of omics data."

National law and European directives, regulations and guidelines regulate development of medicinal product and medical devices. A product's successful journey from research to market and eventually patients requires a well-designed regulatory strategy and several consultations with regulatory authorities.

Dr. Elana Fertig, Associate Professor of Oncology and Applied Mathematics and Statistics Assistant Director of the Sydney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, USA, will present the lecture "Uncovering hidden sources of transcriptional dysregulation arising from inter- and intra-tumor heterogeneity."

Dr. Francesca Buffa, Associate Professor, Computational Biology and Integrative Genomics, Department of Oncology, CRUK/MRC Institute, University of Oxford, will present the lecture "In-silico modelling of the tumour microenvironment."

What are the most important skills you need to have as an entrepreneur and why is your business model just as important as your product?

Dr. Céline Vallot, Principal Investigator of the "Dynamics of epigenetics plasticity in cancer" group at the Curie Institute, Paris, France, will present the lecture "Tracking the dynamics of chromatin states in tumor cells at single-cell resolution: response and resistance to cancer therapies."

Funding and partnering is critical when you want to commercialize an academic idea. What are the pitfalls? What is critical? What are the dos and don'ts?

Dr. Stephan Ossowski, Group Leader at the Institute for Medical Genetics and Applied Genomics, University of Tübingen, Germany, will present the lecture "Computational Analysis of NGS Data for Clinical Diagnostics."

Livsvitskapsbygget ved UiO skal stå ferdig i 2024. Første spadetak blir teke første kvartal 2019. Ein stor brukarorganisasjon har vore i sving siste halvåret og UiO får innspel frå eksterne aktører. Få med deg siste nytt om byggeprosjektet og vegen vidare. 

Dr. Alfonso Valencia, Group Leader and Director of the Life Sciences Department of the Barcelona Supercomputing Center, will present the lecture "Networks based approaches in biology and biomedicine."

Hvordan påvirker utseendet vårt hvilke muligheter vi har på arbeidsmarkedet og vår sosiale status? 

Det nye livsvitenskapsbygget ved UiO skal bidra til økt verdiskaping og økt internasjonal konkurransekraft innen livsvitenskap. For å realisere visjonen trenger UiO å høre hvilke forventninger eksterne aktører har til bygget. 

Thomas Hanke EVP, Head of Academic Partnerships at Evotec AG will share his insights on successful models for academia–industry collaboration and lessons learned from evaluating and advancing early stage academic innovations into successful industry projects. He will also introduce Evotec’s BRIDGE concept.

What does responsible research within the Life Sciences mean today, and how can the human and social sciences contribute in this discussion? The Science Studies Colloquium arranges a panel debate, open for everyone, aiming at discussing these questions.

Honorary guest and speaker: Holberg Prize Winner and Professor Julia Kristeva, Université Paris Diderot. Key note speakers:  Professor Marie Rose Moro, Université Paris Descartes, Professor Brian Hurwitz, King's College London and Professor Trish Greenhalgh, University of Oxford.

Roundtable discussion chaired by Brandy Schillace, Editor-in-chief of BMJ’s Medical Humanities Journal (London). Commentary to Julia Kristeva's lecture by Prof. Rosemarie Garland-Thomson (Emory University).

Lecture by Professor Jerome S. Engel "Innovation in the Digital Age: How does it impact health care and the life sciences?"